Association of the neutrophil-to-lymphocyte ratio and prostate cancer detection rates in patients via contemporary multi-core prostate biopsy

Association of the neutrophil-to-lymphocyte ratio and prostate cancer detection rates in patients via contemporary multi-core prostate biopsy

The aim of this study was to determine whether the neutrophil-to-lymphocyte ratio (NLR), a measure of the systemic inflammatory response is associated with the overall prostate cancer detection rate in men who underwent contemporary multi (≥12)-core transrectal ultrasound (TRUS) biopsy. We reviewed...

Full description

Bibliographic Details
Main Authors:	Jong Jin Oh, Ohsung Kwon, Jung Keun Lee, Seok-Soo Byun, Sang Eun Lee, Sangchul Lee, Sung Kyu Hong
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Asian Journal of Andrology
Subjects:	inflammation; lymphocyte; neutrophil; prostate biopsy; prostate cancer
Online Access:	http://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=6;spage=937;epage=941;aulast=Oh

Similar Items

Predictive Value of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio Measured Prior to Prostate Biopsy
by: Hüseyin Eren
Published: (2020-03-01)

Are neutrophil-lymphocyte and platelet-lymphocyte ratios valuable in predicting prostate cancer?
by: Ahmet Camtosun, et al.
Published: (2016-12-01)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

An inflammatory marker for predicting prostate cancer in prostate biopsy: monocyte-to-lymphocyte ratio
by: Mehmet Kutlu Demirkol, et al.
Published: (2021-06-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
by: Muhsin Balaban, et al.
Published: (2019-01-01)

The Role Of Blood Neutrophil / Lymphocyte Distribution in The Diagnosis Of Prostate Cancer
by: Deniz, M. Eflatun, et al.
Published: (2020-06-01)

Repeated biopsy in the detection of prostate cancer: When and how many cores
by: Vincenzo Scattoni, et al.
Published: (2014-12-01)

Development and validation of a nomogram including lymphocyte-to-monocyte ratio for initial prostate biopsy: a double-center retrospective study
by: Zhong-Han Zhou, et al.
Published: (2021-01-01)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer
by: Sat Prasad Nepal, et al.
Published: (2023-04-01)

Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy
by: Sangjun Yoo, et al.
Published: (2020-06-01)

Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy
by: Renato Caretta Chambó, et al.
Published: (2015-02-01)

Second to fourth digit ratio: its relationship with core cancer volume and Gleason score in prostate biopsy
by: Jin Kyu Oh, et al.
Published: (2012-10-01)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pietro Pepe, et al.
Published: (2015-10-01)

Nonspecific Presentation of a Multiloculated Prostatic Abscess After Transurethral Prostatic Biopsy for Elevated Prostate-specific Antigen Level
by: Nilay M. Gandhi, et al.
Published: (2014-11-01)

The Severity of Pain in Prostate Biopsy Depends on the Biopsy Sector
by: Grzegorz Rempega, et al.
Published: (2023-02-01)

A review of transrectal ultrasound guided prostate biopsies: Is there still a role for finger guided prostate biopsies?
by: K.S. Jehle, et al.
Published: (2015-03-01)

Clinical Value of Core Lenght in Saturation Prostate Biopsy
by: Cem Yücel, et al.
Published: (2018-06-01)

Routine systematic prostate biopsies not replaced by magnetic resonance imaging-targeted biopsy
by: David Gómez-Ortiz, et al.
Published: (2022-10-01)

Correlation between neutrophil–to-lymphocyte ratio with Gleason score in patients with prostate cancer at Adam Malik Hospital Medan 2013 – 2015
by: Michael Rulando, et al.
Published: (2021-01-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

Morbidity following transperineal prostate biopsy: Our experience in 8.500 men
by: Pietro Pepe, et al.
Published: (2022-06-01)

Rebiopsy rate after transperineal or transrectal prostate biopsy
by: Jose L. Marenco Jimenez, et al.
Published: (2021-06-01)

A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer
by: Carmelo Agostino Di Franco, et al.
Published: (2017-03-01)

Can Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates Predict Bone Metastasis in Prostate Cancer Patients?
by: Yeşim Ceylan, et al.
Published: (2019-06-01)

The diagnostic ability of an additional midline peripheral zone biopsy in transrectal ultrasonography-guided 12-core prostate biopsy to detect midline prostate cancer
by: Inpyeong Hwang, et al.
Published: (2016-01-01)

COMPARATIVE EVALUATION OF CURRENT METHODS OF ANESTHESIA IN PERFORMANCE OF TRANSRECTAL PROSTATE BIOPSY
by: M. E. Topuzov, et al.
Published: (2015-10-01)

Metastasectomy for rectal wall seeding of prostate adenocarcinoma after transrectal prostate biopsy
by: E Matthew DiLizia, et al.
Published: (2021-01-01)

Correlation between peripheral blood neutrophil-lymphocyte ratio and CD34 expression in prostate cancer
by: Yiyang Wang, et al.
Published: (2020-09-01)

How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density
by: Jae Yeon Kim, et al.
Published: (2023-09-01)

Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis
by: Ahmad AE, et al.
Published: (2019-11-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

Complications of Transrectal Prostate Biopsy
by: Cech P., et al.
Published: (2014-05-01)

What is the ideal number of biopsy cores per lesion in targeted prostate biopsy?
by: Gokhan Sonmez, et al.
Published: (2020-09-01)

Transrectal ultrasound and needle biopsy of the prostate
by: Tomaž Smrkolj
Published: (2016-01-01)

Impact of Prostate Needle Biopsy on Erectile Function
by: Fatih Yanaral, et al.
Published: (2019-03-01)

Safety of 12 core transrectal ultrasound guided prostate biopsy in patients on aspirin
by: Pawan Vasudeva, et al.
Published: (2015-12-01)

Comparison of Grading Accuracy of Prostate Cancer in Samples Acquired by a Targeted and Systemic Prostate Biopsy
by: Ivan Pezelj, et al.
Published: (2022-01-01)

Prostate biopsies containing prostate intraepithelial neoplasia and atypical small acinar proliferation: what to do?
by: Fernando Korkes, et al.
Published: (2009-12-01)